By: Mark Shen, Pharm.D. Candidate c/o 2012

Adding to Ms. Liaw’s article, my preparation for the ASHP Midyear Clinical Meeting included creating and printing my curriculum vitae, printing my transcript, searching for sites that I was interested in, and thinking of questions to ask the residents and residency directors.  I also had to contact the residency site directors to ask if they participated in the Personnel Placement Service (PPS).  If they did participate in PPS, I scheduled days and times to interview with the sites.  It was important to ensure that I did not schedule too many interviews per day – I needed enough time to visit the residency showcase to speak with other residency directors and residents.  Since the residency sessions changed each day (and even during some parts of the day), it was important for me to manage my time properly and map out the sites that I wanted to visit.

Since I had printed maps with marked locations and booth numbers of each site, the meeting was not as chaotic as I had previously imagined.  It was imperative for me to prioritize and manage my time effectively, but if I had the chances, I would have liked to look at other residency sites and educational events.

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago